E
Tonix Pharmaceuticals Holding Corp. TNXP
$38.00 $2.156.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -9.51% -2.14% -31.68% -29.26% --
Total Other Revenue -- -- -- -- --
Total Revenue -9.51% -2.14% -31.68% -29.26% --
Cost of Revenue -2.82% -43.19% -50.02% -34.50% --
Gross Profit -9.92% 80.78% -0.92% -21.55% --
SG&A Expenses 115.97% 8.53% 34.08% -11.54% 6.77%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 47.29% -22.45% -19.44% -42.82% -29.08%
Operating Income -54.13% 24.81% 17.74% 44.74% 36.70%
Income Before Tax 64.11% -12.65% 19.08% 49.19% -177.81%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 64.11% -12.65% 19.08% 49.19% -177.81%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 64.11% -12.65% 19.08% 49.19% -177.81%
EBIT -54.13% 24.81% 17.74% 44.74% 36.70%
EBITDA -65.49% 23.50% 16.73% 44.63% 39.62%
EPS Basic 99.80% 99.47% 99.55% -- --
Normalized Basic EPS 99.20% 99.54% -- -- --
EPS Diluted 99.80% 99.47% 99.55% -- --
Normalized Diluted EPS 99.20% 99.54% -- -- --
Average Basic Shares Outstanding 17,771.46% 21,144.44% -- -- --
Average Diluted Shares Outstanding 17,771.46% 21,144.44% 18,008.00% -- --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --